FAP and malignant colon neoplasm: Such increased cytotoxicity induced by FAP-4-1BBL was also observed when treating the CEAlow colon cancer organoid (53436) that did not experience cytotoxicity in the presence of the CEA-TCB T cell engager alone (Figure 6F and G and Figure S6).